Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients-Reference-Cited by-同舟云学术

Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients

Published:2020-09-16 Issue:12 Volume:95 Page:1511-1521
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Morsia Erika¹,McCullough Kristen¹^ORCID,Joshi Maansi¹,Cook Joselle¹^ORCID,Alkhateeb Hassan B.¹,Al‐Kali Aref¹,Begna Kebede¹^ORCID,Elliott Michelle¹^ORCID,Hogan William¹,Litzow Mark¹^ORCID,Shah Mithun¹,Pardanani Animesh¹,Patnaik Mrinal¹^ORCID,Tefferi Ayalew¹^ORCID,Gangat Naseema¹

Affiliation:

1. Division of Hematology Mayo Clinic Rochester Minnesota USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25978

Reference30 articles.

1. Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse?

2. Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study

3. Acute myeloid leukemia: 2019 update on risk-stratification and management

4. How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relapse and resistance in acute myeloid leukemia post venetoclax: improving second lines therapy and combinations;Expert Review of Hematology;2024-09-13

2. Global, regional, and national burden of acute myeloid leukemia, 1990–2021: a systematic analysis for the global burden of disease study 2021;Biomarker Research;2024-09-11

3. Investigations on druggable gene mutations related to AML/ALL lineage genes in Advanced Phases of CML: Implications in patient-tailored therapy of blast crisis CML in TKI era;2024-09-09

4. Clinical management of patients diagnosed with acute myeloid leukemia treated with venetoclax in combination with hypomethylating agents after achieving a response: a real-life study;Annals of Hematology;2024-08-29

5. A systematic review of venetoclax for the treatment of unfit AML patients in real-world: is all that glitters gold?;Annals of Hematology;2024-08-16